Klotho Neurosciences Terminates Share Agreement with SkyBell, Enhances Focus on Longevity Research Klotho Neurosciences has mutually ended its share exchange agreement with SkyBell Technologies, allowing a refocused strategy on therapeutic advancements and longevity research.

Klotho Neurosciences Terminates Share Agreement with SkyBell, Enhances Focus on Longevity Research #United_States #New_York #Therapeutics #Klotho_Neurosciences #SkyBell_Technologies